Skip to main content
Evotec SE logo

Evotec SE — Investor Relations & Filings

Ticker · EVT ISIN · DE0005664809 LEI · 529900F9KI6OYITO9B12 F Professional, scientific and technical activities
Open in API
Filings indexed 1,778 across all filing types
Latest filing 2016-12-15 M&A Activity
Country DE Germany
Listing F EVT

About Evotec SE

https://www.evotec.com/en

Evotec SE is a life science company focused on drug discovery and development in partnership with pharmaceutical and biotechnology firms. The company operates an integrated research and development value chain, utilizing proprietary technology platforms that incorporate AI-driven innovation and induced pluripotent stem cells (iPSC). Its expertise spans a wide range of therapeutic modalities, from small molecules to biotherapeutics. Through its Just – Evotec Biologics division, the company offers end-to-end solutions for the design, development, and manufacturing of biologic therapies, aiming to enhance their accessibility and affordability. Evotec employs flexible partnering models to accelerate the delivery of new treatments to patients with high efficiency and quality.

Recent filings

Filing Released Lang Actions
EVOTEC COMPLETES ACQUISITION OF CYPROTEX PLC
M&A Activity Classification · 98% confidence The document is a press release dated December 15, 2016, announcing the successful completion of the acquisition of Cyprotex PLC by Evotec AG. It details the terms of the acquisition (£55.7m cash), the regulatory process (scheme of arrangement regulated by the UK takeover code), and the strategic rationale. This content directly relates to a significant corporate transaction, specifically a merger or takeover activity. Therefore, the most appropriate classification is 'M&A Activity' (TAR).
2016-12-15 English
Declaration of Voting Results & Voting Rights Announcements 2016
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains sections detailing the 'Notification of Major Holdings' including the date the threshold was crossed (09 Dec 2016), the resulting percentage of voting rights (2.96%), and the shareholder involved (Ministry of Finance on behalf of the State of Norway). This content directly corresponds to regulatory filings concerning changes in significant share ownership, which maps precisely to the Major Shareholding Notification category (MRQ). Although it is a regulatory announcement disseminated via DGAP, the specific nature of the content (major holding change) overrides the general 'RNS' fallback.
2016-12-13 English
Declaration of Voting Results & Voting Rights Announcements 2016
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed sections regarding the 'Notification of Major Holdings' under German securities law (WpHG). It details the acquisition/disposal of shares with voting rights by the Ministry of Finance on behalf of the State of Norway, crossing a threshold (3.01%). This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership levels crossing defined thresholds. The code for this is MRQ.
2016-12-12 English
EVOTEC AND FORGE THERAPEUTICS FORM STRATEGIC 'SUPERBUG' ALLIANCE
M&A Activity Classification · 99% confidence The document is a press release dated December 9, 2016, announcing a strategic alliance between Evotec AG and Forge Therapeutics regarding an antibiotic program. It contains standard press release formatting, including a headline, date, company boilerplate information, and forward-looking statements. This type of announcement, detailing a partnership or business development, does not fit neatly into the specific financial reporting categories (like 10-K, ER, IR) or specific corporate actions (like DIV, SHA, POS). Since it is a general corporate news announcement disseminated via DGAP (a service often used for regulatory news), and it doesn't fit any other specific category, the most appropriate fallback is Regulatory Filings (RNS), which covers general regulatory announcements.
2016-12-09 English
Entsprechenserklärung zum Deutschen Corporate Governance Kodex für das Jahr 2016
Governance Information Classification · 99% confidence The document title is "Entsprechenserklärung zum Deutschen Corporate Governance Kodex für das Jahr 2016" (Declaration of Conformity with the German Corporate Governance Code for the Year 2016). The text explicitly discusses compliance with the German Corporate Governance Code (Kodex), referencing specific articles (e.g., Artikel 4.2.3, Artikel 3.8) and legal statutes (§ 161 Aktiengesetz). This type of declaration detailing internal rules, board structure, and governance practices directly aligns with the definition of Governance Information. It is not an Annual Report (10-K), an Earnings Release (ER), or a simple announcement of a report (RPA), but the report itself detailing governance compliance. Therefore, the appropriate code is CGR (Governance Information).
2016-12-01 German
Declaration of Compliance with the German Corporate Governance Code for the year 2016
Governance Information Classification · 99% confidence The document is explicitly titled 'Declaration of Compliance with the German Corporate Governance Code for the year 2016'. It details the company's adherence (or exceptions) to the recommendations of the German Corporate Governance Code (Section 161 of the German Stock Corporation Act). This content directly relates to the company's internal rules, board structure, and governance practices, making it a Governance Information document.
2016-12-01 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.